GAVI

in page functions

23 January 2015

Dagfinn Høybråten, 
Board Chair, Gavi, the Vaccine Alliance

Biography of Dagfinn Høybråten, Chair of Gavi, the Vaccine Alliance Board.

18 June 2014

GAVI Alliance Progress Report 2013

The annual progress report gives a comprehensive overview of the activities and performance of the GAVI Alliance, illustrating the work and achievements of this public-private partnership.

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 79

15 August 2013

Factsheet: Rotavirus disease

GAVI's support for the introduction of the rotavirus vaccine into national immunisation programmes targets the leading cause of death due to diarrhoea in children under five in low-income countries. [French]

01 August 2013

GAVI Matching Fund brochure

The GAVI Matching Fund A public-private partnership to save children’s lives innovative finance April 2013The challengeAbdul, Sierra Leone1 Abdul, a young boy in Sierra Leone, was one of the lucky ones. He was severely dehydrated, weak from diarrhoea and barely able to move. Abdul was suffering from rotavirus, the lead

  • Author(s):
  • GAVI Alliance
  • Publisher:
  • Gavi

18 July 2013

Factsheet: Measles and rubella

2013 marks a dramatic shift in the health of mothers and infants. For the first time GAVI is addressing measles and rubella simultaneously. This is a major step in accelerating global progress to controll two life-threatening diseases with a cost-effective vaccine.

18 July 2013

Factsheet: Pneumococcal disease

GAVI's support for the introduction of the pneumococcal vaccine into national immunisation programmes tackles diseases that claim the lives of more than a million people every year, including more than half a million children before their fifth birthday, mainly in low-income countries. [Spanish] [French]

10 June 2013

GAVI Alliance Progress Report 2012

The annual progress report gives a comprehensive overview of the activities and performance of the GAVI Alliance, illustrating the work and achievements of this public-private partnership. [French]

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 66

09 May 2013

Healthy girls, healthy women. Facts & Figures

Starting in 2013, GAVI is supporting the poorest countries of the world to roll out two vaccines that will directly benefit women and girls. Vaccinating girls with human papillomavirus vaccines will help protect future generations of women against cervical cancer. Rubella vaccine protects babies from birth defects associated with congenital rubella syndrome, and helps to prevent miscarriage and stillbirth.
 

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 20
  • Publisher:
  • Gavi

01 May 2013

GAVI Innovative Finance brochure

GAVI’s mission is to save children’s lives and protect people’s health by increasing access to immunisation in poor countries. To that end, GAVI has become a leading force in the use of innovative finance to fund development initiatives that help GAVI. Learn more in this brochure.
 

  • Publisher:
  • Gavi

18 April 2013

Factsheet: Shaping vaccine markets

Maintaining a healthy vaccine market is at the core of the GAVI Alliance mission and business model. As a result, GAVI has a strategic goal to shape markets to make sure a sufficient supply of high-quality and appropriate vaccines is available to developing countries at low and sustainable prices.

25 March 2013

GAVI Alliance Partnership with the ACP States

Protecting children’s health through immunisation in the African, Caribbean, and Pacific Group of States [French]
 

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 8
  • Publisher:
  • Gavi

26 November 2012

Factsheet: Co-Financing vaccines

Co-financing is a cornerstone of the GAVI Alliance’s commitment to building country ownership and ensuring the sustainability of vaccine funding. It is a driving principle in the funding of vaccines and is a core element of GAVI’s financing goal in the 2011-2015 strategy.

23 November 2012

GAVI Alliance Progress Report 2011

The annual progress report gives a comprehensive overview of the activities and performance of the GAVI Alliance, illustrating the work and achievements of this public-private partnership. [French]

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 68

23 November 2012

Factsheet: Advance Market Commitment

Learn about Advance Market Commitment, including the pilot AMC for pneumococcal vaccines.

23 November 2012

23 November 2012

Factsheet: Equity in immunisation

GAVI’s mission – to save children’s lives and protect people’s health by increasing access to immunisation in poor countries – is underpinned by the basic tenet of equity. Access to the benefits of vaccines should not depend on where in the world a child is born.

22 November 2012

Factsheet: GAVI collaboration with civil society

Civil society organisations (CSOs) have a long history of involvement in public health and have proven to be particularly successful in reaching marginalised populations and people in remote areas, especially through community mobilisation. [French]

23 February 2012

Factsheet: Protecting women's and children's health

Learn about the inextricable link between child and maternal mortality, and how an integrated approach can accelerate progress towards achieving the health Millennium Development Goals. [Deutsch]

  • Publisher:
  • Gavi

10 January 2012

Gender-related barriers to vaccination services-information note

Guidance on how to include gender in health system strengthening funding requests based on national health strategies, using the GAVI-Global Fund joint Funding Request Template.

  • Total pages:
  • 3
  • Publisher:
  • Gavi

07 September 2011

Factsheet: vaccines and non-communicable diseases

Non-communicable diseases ( NCDs ) are the leading causes of death globally. NCDs killed 36 million people in 2008, representing 63 % of global deaths, principally from cardiovascular diseases, diabetes, cancer and chronic respiratory infections. [German] [French]
 

01 August 2011

Factsheet: Health system strengthening

Learn about GAVI's involvement in health system strengthening. [French]

 

20 June 2011

GAVI Alliance Progress Report 2010

Marking the end of GAVI's first decade, the 2010 Progress Report shows how unprecedented demand, accelerated access to vaccines and strong country ownership have helped save over five million future deaths. [French]

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 68

02 May 2011

Factsheet: Investing in vaccines

If fully funded, GAVI can accelerate access to new vaccines that will save a further four million lives by 2015. [French]

08 December 2010

Factsheet: A decade of saving lives

The GAVI Alliance was launched in 2000, at a time when the distribution of vaccines to children in the poorest parts of the world had begun to falter. [French]

  • Publisher:
  • Gavi

01 June 2010

GAVI Alliance Progress Report 2009

GAVI's 2009 Progress Report paints a picture of developing country commitment and ownership of GAVI programmes. By the end of the year, over 250 million additional children had been vaccinated through GAVI support. [French]

  • Total pages:
  • 68
  • Publisher:
  • Gavi

04 May 2010

GAVI Alliance support for civil society organisations in Ethiopia

GAVI’s health system strengthening support to Ethiopia is US$ 76,494,000 for 2007 to 2009, and CSO support amounts to US $ 3,420,000 over a two year period from 2008 to 2010. The objectives of the GAVI Alliance for CSO support in Ethiopia are to increase immunisation coverage within seven regions, three of which – Somali, Gambella, and Afar –, have the lowest immunisation rates in the country. The focus of the support will be directed to hard-to-reach and marginalised populations.

 

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 4
  • Publisher:
  • Gavi

04 May 2010

GAVI Alliance support for civil society organisations in DR Congo

US$ 5.41 million have been approved by GAVI for CSO support from 2007 to 2010. The grant was channelled through an already established network of non-governmental organisations (NGOs) that then issued subgrants to other NGOs for

implementation. This has resulted in significant achievements within the first year of implementation.

 

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 4
  • Publisher:
  • Gavi

04 May 2010

GAVI Alliance support for civil society organisations in Pakistan

GAVI’s CSO support to Pakistan amounts to US$ 4,587,000 over a two-year period from 2009 to 2010. The GAVI CSO grant provides an opportunity to improve the partnership between CSOs and the government of Pakistan. CSOs have traditionally

worked with the government on an ad hoc basis, with weak linkages and coordination between the two sectors at both the central and lower levels.

 

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 4
  • Publisher:
  • Gavi

21 April 2010

GAVI Alliance funding for civil society organisations: case studies

The purpose of these case studies is to document experiences and lessons learned under the GAVI CSO grant, including the application and selection process, implementation to date, and monitoring and reporting.

 

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 72
  • Publisher:
  • Gavi

01 October 2009

Factsheet: GAVI's Accelerated Vaccine Introduction Initiative

GAVI launched the AVI initiative in January 2009 to facilitate the rapid and large-scale introduction of pneumococcal and rotavirus vaccines in GAVI-eligible countries and to establish a platform for future introduction of other new vaccines.

  • Publisher:
  • Gavi

01 June 2009

GAVI Alliance Progress Report 2008

By the end of 2008, 3.4 million future deaths have been averted through GAVI support for vaccines. In 2008, GAVI undergoes governance and administrative changes, becoming a Swiss international organisation.

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 72
  • Publisher:
  • Gavi

25 July 2008

GAVI Alliance Progress Report 2007

2007 was a landmark year for GAVI: it was the initial year of GAVI's first strategic plan; the new health system strengthening programme starts; over 80% of countries eligible for support receive funding for NVS, INS and ISS.

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 84
  • Publisher:
  • Gavi

25 July 2008

GAVI Alliance Progress Report 2007 Summary

2007 was a landmark year for GAVI: it was the initial year of GAVI's first strategic plan; the new health system strengthening programme starts; over 80% of countries eligible for support receive funding for NVS, INS and ISS.

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 13
  • Publisher:
  • Gavi

01 September 2007

GAVI Alliance Progress Report 2006

2007 was a landmark year for GAVI: it was the initial year of GAVI's first strategic plan; the new health system strengthening programme starts; over 80% of countries eligible for support receive funding for NVS, INS and ISS.

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 82
  • Publisher:
  • Gavi

01 September 2006

GAVI Alliance Progress Report 2005

In the first five years of GAVI, 15 million more children were reached with basic vaccines, 99 million were reached with new vaccines and 1.2 billion auto-disable syringes were delivered. 

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 50
  • Publisher:
  • Gavi

01 September 2005

GAVI Alliance Progress Report 2004

After five years in operation, 71 countries out of 75 GAVI-eligible countries have received GAVI support, with one third of resources directed toward strengthening health systems in poorest countries.

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 72
  • Publisher:
  • Gavi

01 September 2004

GAVI Alliance Progress Report 2003

Four years after launch, more than 500,000 lives have been saved because of GAVI support. More than 35 million children have been immunised against hepatitis B, including a co-funding partnership with China.

  • Author(s):
  • The Vaccine Fund, GAVI Alliance
  • Total pages:
  • 57
  • Publisher:
  • Gavi

01 September 2003

GAVI Alliance Progress Report 2002

By the end of 2002, GAVI funded has supported the delivery of new and underused vaccines and safe, disposable syringes to 55 of the world's poorest countrie. Five-year commitments worth US$ 900 million made to 64 countries.

  • Author(s):
  • The Vaccine Fund, GAVI Alliance
  • Total pages:
  • 56
  • Publisher:
  • Gavi

01 June 2002

GAVI Alliance Progress Report 2001

GAVI has already delivered on in its commitments to the world's poorest children, with support for immunisation programmes against hepatitis B, Haemophilus influenzae type b, yellow fever and DTP3.

  • Author(s):
  • GAVI Alliance
  • Total pages:
  • 21
 



close icon

modal window here